Treatment of infections caused by carbapenemase-producing Enterobacterales
Rev. esp. quimioter
; 35(Supl. 3): 46-50, Oct. 2022. tab
Article
en En
| IBECS
| ID: ibc-210748
Biblioteca responsable:
ES1.1
Ubicación: ES15.1 - BNCS
ABSTRACT
Antibiotic resistance is one of the main menaces to public and individual health worldwide. In the last two decades, an increase in the detection of arbapenem-resistant Enterobacterales has been reported. The treatment of infections caused by these strains is a therapeutic challenge. The use of carbapenems may be beneficial depending on MIC value and source of infection. New drugs, with different activity against the different classes of carbapenemases, are developed showing significant benefits. (AU)
Palabras clave
Texto completo:
1
Colección:
06-national
/
ES
Base de datos:
IBECS
Asunto principal:
Farmacorresistencia Microbiana
/
Enterobacteriaceae Resistentes a los Carbapenémicos
Límite:
Humans
Idioma:
En
Revista:
Rev. esp. quimioter
Año:
2022
Tipo del documento:
Article